Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2018/4273231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563295991627776 |
|---|---|
| author | Benjamin Chaucer Abriella Stone Augustus Demanes Shawn M. Seibert |
| author_facet | Benjamin Chaucer Abriella Stone Augustus Demanes Shawn M. Seibert |
| author_sort | Benjamin Chaucer |
| collection | DOAJ |
| description | The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common side effects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of an extremely rare side effect to a common chemotherapeutic agent. |
| format | Article |
| id | doaj-art-700f77a0b06547fd8b172879a2fac09f |
| institution | Kabale University |
| issn | 2090-6706 2090-6714 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Oncological Medicine |
| spelling | doaj-art-700f77a0b06547fd8b172879a2fac09f2025-02-03T01:20:30ZengWileyCase Reports in Oncological Medicine2090-67062090-67142018-01-01201810.1155/2018/42732314273231Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer SyndromeBenjamin Chaucer0Abriella Stone1Augustus Demanes2Shawn M. Seibert3University of Illinois College of Medicine at Peoria, Peoria, IL, USAUniversity of Illinois College of Medicine at Peoria, Peoria, IL, USAUniversity of Illinois College of Medicine at Peoria, Peoria, IL, USAIllinois Cancer Care, Peoria, IL, USAThe treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common side effects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of an extremely rare side effect to a common chemotherapeutic agent.http://dx.doi.org/10.1155/2018/4273231 |
| spellingShingle | Benjamin Chaucer Abriella Stone Augustus Demanes Shawn M. Seibert Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome Case Reports in Oncological Medicine |
| title | Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome |
| title_full | Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome |
| title_fullStr | Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome |
| title_full_unstemmed | Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome |
| title_short | Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome |
| title_sort | nivolumab induced encephalitis in hereditary leiomyomatosis and renal cell cancer syndrome |
| url | http://dx.doi.org/10.1155/2018/4273231 |
| work_keys_str_mv | AT benjaminchaucer nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome AT abriellastone nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome AT augustusdemanes nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome AT shawnmseibert nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome |